Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
LaNova Medicines Announces Global Exclusive License Agreement with AstraZeneca for LM-305, a Novel GPRC5D-Targeting Antibody Drug Conjugate 2023-05-12 23:30
Crystal Formulation Services' GMP Manufacturing Facility Successfully Passes the Remote Audit by US Client, Marking a Key Milestone for Its International Expansion 2023-05-12 21:00
Kintor Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US 2023-05-11 23:30
Fosun Pharma Participates in BEYOND Expo 2023 to Showcase Its Innovative R&D Achievements 2023-05-10 22:57
CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology 2023-05-09 22:07
PharmAbcine to participate in "BIO International Convention 2023" 2023-05-08 20:00
Chance Pharmaceuticals and Acorda Therapeutics Announce Agreement to Provide INBRIJA® in Greater China 2023-05-08 19:30
Neuro3 Therapeutics Acquires Exclusive Worldwide Rights to Develop and Commercialize Clinical Stage KCNQ2 Activators from Lundbeck 2023-05-08 14:00
BLISS BIOPHARMACEUTICAL ENTERS INTO A CLINICAL TRIAL COLLABORATION AGREEMENT WITH AN OPTION OF STRATEGIC COLLABORATION WITH EISAI FOR BB-1701 2023-05-08 07:00
NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE 2023-05-08 04:00
Suzhou GenAssist Therapeutic Co.,Ltd recently announced that its first base editing product, GEN6050, has submitted a pre-IND application to the FDA and has been accepted 2023-05-06 21:00
Empowering Innovation to the Global Market with Acro Certify 2023-05-06 10:18
CARsgen's CLDN18.2 mAb AB011 Achieves IND Clearance from the NMPA for the First-line Combination Treatment of Gastric Cancer 2023-05-05 20:50
ProQure and Identiv Partner to Launch Innovative NFC Type 2 Tags for Large-Scale NFC Deployments 2023-05-05 18:00
Formosa Pharmaceuticals and AimMax Therapeutics Announce the NDA Submission to the US FDA for APP13007 for the Treatment of Post-Operative Inflammation and Pain following Ocular Surgery 2023-05-05 08:00
Recall Notice - SD Biosensor, Inc. requests discontinuation of use and disposal of specific Pilot™ COVID-19 At-Home Tests in the United States due to microbial contamination in the liquid buffer solution 2023-05-05 04:00
ABM Announces First Patient Dosed in Phase I Clinical Trial of MEK Inhibitor for Solid Tumor 2023-05-05 01:00
Hasten Biopharma Acquires Commercial Rights in China for Roche's Antibiotic Rocephin® 2023-05-04 14:00
EDAN Announces Integration with PointClickCare for Better Senior Primary Care 2023-05-03 21:56
Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting 2023-05-03 12:00
1 50 51 52 53 54 165